{
  "schema_version": "0.1.0",
  "id": "fda-drug-shortage:dexamethasone-sodium-phosphate-injection",
  "slug": "dexamethasone-sodium-phosphate-injection",
  "title": "FDA shortage status: Dexamethasone Sodium Phosphate Injection",
  "ingredient": "Dexamethasone Sodium Phosphate Injection",
  "status": "current",
  "source_statuses": [
    "Current"
  ],
  "brand_names": [
    "DEXAMETHASONE SODIUM PHOSPHATE"
  ],
  "therapeutic_categories": [
    "Dermatology",
    "Endocrinology/Metabolism",
    "Gastroenterology",
    "Hematology",
    "Neurology",
    "Oncology",
    "Ophthalmology",
    "Other",
    "Pulmonary/Allergy",
    "Rheumatology"
  ],
  "dosage_forms": [
    "Injection"
  ],
  "routes": [
    "INTRA-ARTICULAR",
    "INTRALESIONAL",
    "INTRAMUSCULAR",
    "INTRAVENOUS",
    "SOFT TISSUE"
  ],
  "package_count": 19,
  "packages": [
    {
      "package_ndc": "55150-304-25",
      "product_ndc": "55150-304",
      "company_name": "Eugia US LLC",
      "manufacturer_name": "Eugia US LLC",
      "presentation": "Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 55150-304-25)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAMUSCULAR",
        "INTRAVENOUS"
      ],
      "update_date": "08/06/2026",
      "initial_posting_date": "02/08/2019",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "63323-506-01",
      "product_ndc": "63323-506",
      "company_name": "Fresenius Kabi USA, LLC",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "presentation": "Dexamethasone Sodium Phosphate Preservative Free, Injection, 10 mg/1 mL (NDC 63323-506-01)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAMUSCULAR",
        "INTRAVENOUS"
      ],
      "update_date": "08/04/2026",
      "initial_posting_date": "02/08/2019",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "63323-516-10",
      "product_ndc": "63323-506",
      "company_name": "Fresenius Kabi USA, LLC",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "presentation": "Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 63323-516-10)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAMUSCULAR",
        "INTRAVENOUS"
      ],
      "update_date": "08/04/2026",
      "initial_posting_date": "02/08/2019",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "76045-0212-10",
      "product_ndc": null,
      "company_name": "Fresenius Kabi USA, LLC",
      "manufacturer_name": null,
      "presentation": "Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 76045-0212-10)",
      "availability": "Limited Availability",
      "dosage_form": "Injection",
      "routes": [],
      "update_date": "08/04/2026",
      "initial_posting_date": "02/08/2019",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "76045-212-10",
      "product_ndc": "76045-109",
      "company_name": "Fresenius Kabi USA, LLC",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "presentation": "Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 76045-212-10)",
      "availability": "Limited Availability",
      "dosage_form": "Injection",
      "routes": [
        "INTRAMUSCULAR",
        "INTRAVENOUS"
      ],
      "update_date": "08/04/2026",
      "initial_posting_date": "02/08/2019",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "63323-165-01",
      "product_ndc": "63323-165",
      "company_name": "Fresenius Kabi USA, LLC",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "presentation": "Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 63323-165-01)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAMUSCULAR",
        "INTRAVENOUS"
      ],
      "update_date": "08/04/2026",
      "initial_posting_date": "02/08/2019",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "63323-165-05",
      "product_ndc": "63323-165",
      "company_name": "Fresenius Kabi USA, LLC",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "presentation": "Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 63323-165-05)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAMUSCULAR",
        "INTRAVENOUS"
      ],
      "update_date": "08/04/2026",
      "initial_posting_date": "02/08/2019",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "63323-165-30",
      "product_ndc": "63323-165",
      "company_name": "Fresenius Kabi USA, LLC",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "presentation": "Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 63323-165-30)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAMUSCULAR",
        "INTRAVENOUS"
      ],
      "update_date": "08/04/2026",
      "initial_posting_date": "02/08/2019",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "76045-0210-10",
      "product_ndc": null,
      "company_name": "Fresenius Kabi USA, LLC",
      "manufacturer_name": null,
      "presentation": "Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 76045-0210-10)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [],
      "update_date": "08/04/2026",
      "initial_posting_date": "02/08/2019",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "76045-210-10",
      "product_ndc": "76045-210",
      "company_name": "Fresenius Kabi USA, LLC",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "presentation": "Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 76045-210-10)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRA-ARTICULAR",
        "INTRALESIONAL",
        "INTRAMUSCULAR",
        "INTRAVENOUS",
        "SOFT TISSUE"
      ],
      "update_date": "08/04/2026",
      "initial_posting_date": "02/08/2019",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0641-0367-25",
      "product_ndc": "0641-0367",
      "company_name": "Hikma Pharmaceuticals USA, Inc.",
      "manufacturer_name": "Hikma Pharmaceuticals USA Inc.",
      "presentation": "Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 0641-0367-25)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAMUSCULAR",
        "INTRAVENOUS"
      ],
      "update_date": "08/13/2026",
      "initial_posting_date": "02/08/2019",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0641-6145-25",
      "product_ndc": "0641-0367",
      "company_name": "Hikma Pharmaceuticals USA, Inc.",
      "manufacturer_name": "Hikma Pharmaceuticals USA Inc.",
      "presentation": "Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 0641-6145-25)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRA-ARTICULAR",
        "INTRALESIONAL",
        "INTRAMUSCULAR",
        "INTRAVENOUS",
        "SOFT TISSUE"
      ],
      "update_date": "08/13/2026",
      "initial_posting_date": "02/08/2019",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0641-6146-25",
      "product_ndc": "0641-0367",
      "company_name": "Hikma Pharmaceuticals USA, Inc.",
      "manufacturer_name": "Hikma Pharmaceuticals USA Inc.",
      "presentation": "Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 0641-6146-25)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRA-ARTICULAR",
        "INTRALESIONAL",
        "INTRAMUSCULAR",
        "INTRAVENOUS",
        "SOFT TISSUE"
      ],
      "update_date": "08/13/2026",
      "initial_posting_date": "02/08/2019",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "67457-420-10",
      "product_ndc": "67457-420",
      "company_name": "Mylan Institutional, a Viatris Company",
      "manufacturer_name": "Mylan Institutional LLC",
      "presentation": "Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 67457-420-10)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAMUSCULAR",
        "INTRAVENOUS"
      ],
      "update_date": "08/20/2026",
      "initial_posting_date": "02/08/2019",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "67457-421-30",
      "product_ndc": "67457-420",
      "company_name": "Mylan Institutional, a Viatris Company",
      "manufacturer_name": "Mylan Institutional LLC",
      "presentation": "Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 67457-421-30)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRA-ARTICULAR",
        "INTRALESIONAL",
        "INTRAMUSCULAR",
        "INTRAVENOUS",
        "SOFT TISSUE"
      ],
      "update_date": "08/20/2026",
      "initial_posting_date": "02/08/2019",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "67457-422-54",
      "product_ndc": "67457-420",
      "company_name": "Mylan Institutional, a Viatris Company",
      "manufacturer_name": "Mylan Institutional LLC",
      "presentation": "Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 67457-422-54)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRA-ARTICULAR",
        "INTRALESIONAL",
        "INTRAMUSCULAR",
        "INTRAVENOUS",
        "SOFT TISSUE"
      ],
      "update_date": "08/20/2026",
      "initial_posting_date": "02/08/2019",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "67457-423-12",
      "product_ndc": "67457-420",
      "company_name": "Mylan Institutional, a Viatris Company",
      "manufacturer_name": "Mylan Institutional LLC",
      "presentation": "Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 67457-423-12)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRA-ARTICULAR",
        "INTRALESIONAL",
        "INTRAMUSCULAR",
        "INTRAVENOUS",
        "SOFT TISSUE"
      ],
      "update_date": "08/20/2026",
      "initial_posting_date": "02/08/2019",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "70069-021-25",
      "product_ndc": "70069-021",
      "company_name": "Somerset Therapeutics, LLC",
      "manufacturer_name": "Somerset Therapeutics, LLC",
      "presentation": "Dexamethasone Sodium Phosphate Preservative Free, Injection, 10 mg/1 mL (NDC 70069-021-25)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAMUSCULAR",
        "INTRAVENOUS"
      ],
      "update_date": "07/20/2026",
      "initial_posting_date": "02/08/2019",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "70069-025-10",
      "product_ndc": "70069-025",
      "company_name": "Somerset Therapeutics, LLC",
      "manufacturer_name": "Somerset Therapeutics, LLC",
      "presentation": "Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 70069-025-10)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAMUSCULAR",
        "INTRAVENOUS"
      ],
      "update_date": "07/20/2026",
      "initial_posting_date": "02/08/2019",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    }
  ],
  "availability_counts": {
    "Available": 17,
    "Limited Availability": 2
  },
  "initial_posting_date": "02/08/2019",
  "latest_source_update": "08/20/2026",
  "source_updated_at": "2026-08-22",
  "official_url": "https://api.fda.gov/drug/shortages.json",
  "source_name": "U.S. Food and Drug Administration openFDA Drug Shortages",
  "source_license_url": "https://open.fda.gov/license/",
  "retrieved_at": "2026-08-22T15:54:11+00:00",
  "unknowns": {
    "local_availability": "Unknown. FDA status is nationwide and is not local inventory.",
    "clinical_alternatives": "Not provided. CiteFacts does not publish treatment or substitution advice.",
    "resolution_date": "Unknown unless an FDA source row provides an update date."
  },
  "derivations": {
    "status": "current when a grouped FDA row has Current; otherwise it preserves the available FDA Resolved, Discontinuation, or not-current state.",
    "ingredient_page": "Grouped by FDA generic_name, falling back to openFDA.generic_name.",
    "availability_counts": "Count of non-empty FDA package availability values; it is not a claim about local supply."
  }
}